Alzheimer’s prevention and treatment is always a big topic in the Elder Care and Health Care Industry. Scientists, researchers and doctors are constantly working together to find ways to tackle the unknowns of this issue while educating the public about ways to identify, defer and diagnose the disease early on.
Armed with new knowledge about how neurodegenerative diseases alter brain structures, increasing numbers of neurologists, psychiatrists and other clinicians are adopting quantitative brain imaging as a tool to measure and help manage cognitive declines in patients. These imaging findings can help spur beneficial lifestyle changes in patients to reduce risk for Alzheimer’s disease. “I believe neuroradiology, and especially quantitative MRI technology, will have a huge impact in the future of diagnosis and treatment of Alzheimer’s disease, since there is compelling evidence for the baseline size of hippocampus as a key determinant of risk for future cognitive decline, and since many lifestyle factors can cause atrophy or expansion in the volume of this critical brain structure,” says neurologist Majid Fotuhi, M.D., Ph.D., of Johns Hopkins University.
Full Article here